REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/03/2025
Back to search
Official data from USPTO
SSEAMCYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
11/04/2025
Trademark type
Word
Nice classes
5
Filing date
01/04/2019
Registration date
11/03/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/03/2020
Last transaction
11/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
CAPSHAW,DANIEL
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Life Science Institute, Inc.
Representatives
Danielle I. Mattessich MERCHANT & GOULD P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosacerebral infarctionstroke being apoplexia cerebriacute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosacerebral infarctionstroke being apoplexia cerebriacute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosacerebral infarctionstroke being apoplexia cerebriacute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosacerebral infarctionstroke being apoplexia cerebriacute myocardial infarction and spinal cord injuries
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/03/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
09/28/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/28/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/16/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
06/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2020
PUBO
PUBLISHED FOR OPPOSITION
04/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/03/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/09/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/09/2019
CNSL
SUSPENSION LETTER WRITTEN
09/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/28/2019
ALIE
ASSIGNED TO LIE
08/28/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/20/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/01/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/21/2019
GNRT
NON-FINAL ACTION E-MAILED
02/21/2019
CNRT
NON-FINAL ACTION WRITTEN
02/21/2019
DOCK
ASSIGNED TO EXAMINER
02/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/26/2019
NWAP
NEW APPLICATION ENTERED
01/08/2019
Continuous trademark protection
Get notified about every new filing that threatens SSEAMCYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.